These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 2454721

  • 1. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
    Cognetti F, Pinnarò P, Carlini P, Ruggeri EM, Ambesi Impiombato F, Del Vecchio MR, Giannarelli D, Perrino A.
    Cancer; 1988 Jul 15; 62(2):251-61. PubMed ID: 2454721
    [Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M, Cognetti F, Dodion P, Wildiers J, Rosso R, Rossi A, Gignoux B, Van Rymenant M, Cortes-Funes H, Dalesio O.
    Cancer; 1987 Sep 15; 60(6):1173-7. PubMed ID: 2441836
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P, Dodion PF, Andry G, Chantrain G, Dor P, Buyse M, Van Houtte P, Lemort M, Haesendonck P, Larsimont D.
    Eur J Surg Oncol; 1989 Dec 15; 15(6):568-74. PubMed ID: 2480922
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.
    Tobias JS, Monson K, Gupta N, Macdougall H, Glaholm J, Hutchison I, Kadalayil L, Hackshaw A, UK Head and Neck Cancer Trialists' Group.
    Lancet Oncol; 2010 Jan 15; 11(1):66-74. PubMed ID: 19875337
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease.
    Recondo G, Cvitkovic E, Azli N, Tellez Bernal E, de Vathaire F, Wibault P, Richard JM, Marandas P, Benahmed M, Domenge C.
    Cancer; 1991 Nov 15; 68(10):2109-19. PubMed ID: 1717121
    [Abstract] [Full Text] [Related]

  • 8. Cisplatin-vincristine-bleomycin therapy in squamous cell carcinoma of the head and neck.
    Amrein PC, Fingert H, Weitzman SA.
    J Clin Oncol; 1983 Jul 15; 1(7):421-7. PubMed ID: 6199477
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH, Baker SR, Liepman MK, Ensminger WD.
    Med Pediatr Oncol; 1983 Jul 15; 11(1):12-9. PubMed ID: 6188032
    [Abstract] [Full Text] [Related]

  • 12. Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin combined with radical radiotherapy in advanced head and neck cancer.
    Zidan J, Kuten A, Cohen Y, Robinson E.
    Cancer; 1987 Jan 01; 59(1):24-6. PubMed ID: 2431756
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
    Sridhar KS, Ohnuma T, Biller H, Holland JF, Ambinder EP, Barba J.
    Am J Clin Oncol; 1985 Feb 01; 8(1):55-60. PubMed ID: 2581436
    [Abstract] [Full Text] [Related]

  • 14. Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data.
    Price LA, MacRae K, Hill BT.
    Cancer Treat Rep; 1983 Jun 01; 67(6):535-9. PubMed ID: 6190557
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cisplatin-containing chemotherapy in advanced head and neck cancer.
    Paterson IC, Quilty PM.
    Clin Radiol; 1985 Nov 01; 36(6):607-10. PubMed ID: 2415291
    [Abstract] [Full Text] [Related]

  • 19. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.
    Oral Oncol; 2006 Aug 01; 42(7):675-84. PubMed ID: 16731029
    [Abstract] [Full Text] [Related]

  • 20. [A randomized study comparing cisplatin alone or combined in the palliative treatment of carcinoma of the head and neck. Analysis of a series of 209 patients].
    Chauvergne J, Cappelaere P, Fargeot P, Meeus L, Gary-Bobo J, Klein T, Clavel B, David M.
    Bull Cancer; 1988 Aug 01; 75(1):9-22. PubMed ID: 2451954
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.